Fariborz Kamal
2022
In 2022, Fariborz Kamal earned a total compensation of $2.4M as Chief Operating Officer & President at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $209,418 |
|---|---|
| Option Awards | $1,707,900 |
| Salary | $468,983 |
| Total | $2,386,301 |
Kamal received $1.7M in option awards, accounting for 72% of the total pay in 2022.
Kamal also received $209.4K in non-equity incentive plan and $469K in salary.
Rankings
In 2022, Fariborz Kamal's compensation ranked 1,517th out of 5,683 executives tracked by ExecPay. In other words, Kamal earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,517 out of 5,683 | 73rd |
Division Manufacturing | 763 out of 3,091 | 75th |
Major group Chemicals And Allied Products | 295 out of 1,406 | 79th |
Industry group Drugs | 273 out of 1,307 | 79th |
Industry Biological Products, Except Diagnostic Substances | 70 out of 295 | 76th |
Source: SEC filing on April 12, 2023.
Kamal's colleagues
We found two more compensation records of executives who worked with Fariborz Kamal at 4D Molecular Therapeutics in 2022.